FDA Import Refusal 1FX-8179469-5/10002/1 — MITSUBISHI TANABE PHARMA CORPORATION .
The FDA refused shipment 1FX-8179469-5/10002/1 from MITSUBISHI TANABE PHARMA CORPORATION . (Japan) on Sep 22, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 4 other import refusals on record.
Refusal details
- Date
- Sep 22, 2026
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 61PCP74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 75